MBIO - MUSTANG BIO, INC.
0.8963
-0.053 -5.913%
Share volume: 41,407
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$0.95
-0.05
-0.06%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-15-2024 | 08-13-2024 | 11-08-2024 | 03-28-2025 | 05-14-2025 | 08-08-2025 | 11-07-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 5.231 M | 5.891 M | 1.457 M | -26.000 K | 253.000 K | 885.000 K | 624.000 K | |
| Selling general and admin | 1.427 M | 1.531 M | 1.400 M | -223.000 K | 1.217 M | 787.000 K | 957.000 K | |
| Research and development | 3.804 M | 4.360 M | 57.000 K | 197.000 K | -964.000 K | 98.000 K | -333.000 K | |
| Total expenses | 5.231 M | 8.540 M | 1.457 M | 1.017 M | 253.000 K | 885.000 K | 624.000 K | |
| 63.26% | -82.94% | -30.20% | -75.12% | 249.80% | -29.49% | |||
| Operating income | -5.231 M | -8.540 M | -1.457 M | -1.017 M | -253.000 K | -885.000 K | -624.000 K | |
| Ebit | -5.231 M | -8.226 M | -1.457 M | -1.017 M | -253.000 K | -885.000 K | -624.000 K | |
| Pretax income | -5.191 M | -8.199 M | -1.410 M | -952.000 K | -153.000 K | -762.000 K | -468.000 K | |
| 57.95% | -82.80% | -32.48% | -83.93% | 398.04% | -38.58% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -5.191 M | -8.199 M | -1.410 M | -952.000 K | -153.000 K | -762.000 K | -468.000 K | |
| -57.95% | 82.80% | 32.48% | 83.93% | -398.04% | 38.58% |